VLA-β1 integrin subunit-specific monoclonal antibodies MB 1.1 and MB 1.2: Binding to epitopes not dependent on thymocyte development or regulated by phorbol ester and divalent cations

Hybridoma

Volumn 15, Issue 2, 1996, Pages 125-132

  Von Ballestrem, Christoph G ^a   Uniyal, Shashi ^a   McCormick, John I ^b   Chau, Thu ^a   Singh, Bhagirath ^a   Chan, Bosco M C ^a  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; ANTISERUM; DIVALENT CATION; EPITOPE; INTEGRIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY MB1.1; MONOCLONAL ANTIBODY MB1.2; PHORBOL ESTER; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN;

ANIMAL CELL; ANTIGEN BINDING; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; FLOW CYTOMETRY; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RAT; THYMOCYTE;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGENS, CD29; BINDING SITES; CELL DIFFERENTIATION; CELL LINE; EPITOPES; HYBRIDOMAS; MANGANESE; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; RABBITS; RATS; RATS, INBRED F344; T-LYMPHOCYTES; TETRADECANOYLPHORBOL ACETATE;

EID: 0029969536     PISSN: 0272457X     EISSN: None     Source Type: Journal    
DOI: 10.1089/hyb.1996.15.125     Document Type: Article

References (42)

1. Hemler ME: VLA proteins in the integrin family: Structures, functions, and their role on leukocytes. Annu Rev Immunol 1990; 8:365-400.
2. Hynes RO: Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 1992;69:11-25.
3. Adams JC, and Watt FM: Changes in keratinocyte adhesion during terminal differentiation: Reduction in fibronectin binding precedes α5β1 integrin loss from the cell surface. Cell 1990; 63:425-435.
4. Platenfaber LC, and Hynes RO: Changes in integrin receptors on oncogenetically transformed cells. Cell 1989;56:281-290.
5. Giancotti FG, and Ruoslahti E: Elevated levels of the α5β1 fi-bronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells. Cell 1990;60:849-859.
6. Chan BMC, Matsuura N, Takada Y, Zetter BR, and Hemler ME: in vitro and in vivo consequences of VLA-2 expression on rhabdomyosarcoma cells. Science 1991;251:1600-1602.
7. Martin-Padura I, Bazzon G, Zanetti A, Bemasconi S, Elices MJ, Mantovani A, and Dejana E: A novel mechanism of colon carcinoma cell adhesion to the endothelium triggered by β1 integrin chain. J Biol Chem 1994;269:6124-6132.
8. Qian F, Vaux DL, and Weissman I: Expression of the integrin α4β1 on melanoma cells can inhibit the invasive stages of metastasis formation. Cell 1994;77:335-347.
9. Davis LC, Oppenheimer-Marks N, Bednarczyk JL, McIntyre BW, and Lipsky PE: Fibronectin promotes proliferation of naive and memory T cells by signaling through both the VLA-4 and VLA-5 integrin molecules. J Immunol 1990;145:785-793.
10. Shimizu Y, Van Seventer GA, Horgan KJ, and Shaw S: Costimulation of proliferative responses of resting CD4+ T cells by the interaction of VLA-4 and VLA-5 with fibronectin or VLA-6 with laminin. J Immunol 1990;145:59-67.
11. Nojima Y, Humphries MJ, Mould AP, Komoriya A, Yamada KM, Schlossman SF, and Morimoto C: VLA-4 mediates CD3-dependent CD4+ T cell activation via the CSI alternatively spliced domain of fibronectin. J Exp Med 1990;172:1185-1192.
12. Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 1994;76:301-314.
13. Shimizu Y, Newman W, Gopal TV, Horgan KJ, Graber N, Beall LD, van Seventer GA, and Shaw S: Four molecular pathways of T cell adhesion to endothelial cells: Roles of LFA-1, VCAM-1, and ELAM-1 and changes in pathway hierarchy under different activation conditions. J Cell Biol 1991;113:1203-1212.
14. van Kooyk Y, van de Wiel-van Kemenade E, Weder P, Huijbens RJF, and Figdor CG: Lymphocyte function-associated antigen 1 dominates very late antigen 4 in binding of activated T cells to endothelium. J Exp Med 1993;177:185-190.
15. Luscinskas F, Ding H, and Lichtman AH: P-selectin and vascular cell adhesion molecule-1 mediate rolling and arrest, respectively, of CD4+ T lymphocytes on tumor necrosis factor α-activated vascular endothelium under flow. J Exp Med 1995;181:1179-1186.
16. Babi LF, Moser R, Soler MTP, Picker LJ, Blaser K, and Hauser C: Migration of skin-homing T cells across cytokine-activated human endothelial cell layers involves interaction of the cutaneous lymphocyte-associated antigen (CLA), the very late antigen-4 (VLA-4), and the lymphocyte function associated antigen-1 (LFA-1). J Immunol 1995;154:1543-1550.
17. Berlin C, Bargatze RF, Campbell JJ, von Andrian UH, Szabo MC, Hassien SR, Nelson RD, Berg EL, Erlandsen SL, and Butcher EC: α4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell 1995;80:413-422.
18. Yang X-D, Karin N, Tisch R, Steinman L, and McDevitt HO: Inhibition of insulitis and prevention of diabetes in nonobese diabetic mice by blocking L-selectin and very late antigen 4 adhesion receptors. Proc Natl Acad Sci USA 1993;90:10494-10498.
19. Burkly LC, Jakubowski A, and Hattori M: Protection against adoptive transfer of autoimmune diabetes mediated through very late antigen-4 integrin. Diabetes 1994;43:529-534.
20. Baron JL, Reich EP, Visintin I, and Janeway CA: The pathogenesis of adoptive murine autoimmune diabetes requires an interaction between alpha 4-integrins and vascular cell adhesion molecule-1. J Clin Invest 1994;93:1700-1708.
21. Lenter M, Uhlig H, Hamann A, Jeno P, Imhof B, and Vestweber D: A monoclonal antibody against an activation epitope on mouse integrin chain β1 blocks adhesion of lymphocytes to the endothelial integrin α6β1. Proc Natl Acad Sci USA 1993;90:9051-9055.
22. Wu X, Miyake K, Medina KL, Kincade PW, and Gimble JM: Recognition of murine integrin β1 by a rat anti-stromal cell monoclonal antibody. Hybridoma 1994;13:409-416.
23. Wadsworth SA, Chang AC, Hong MJP, Halvorson MJ, Otto S, and Coligan JE: Expression of a novel integrin β1 chain epitope and anti-β1 antibody-mediated enhancement of fibronectin binding are dependent on the stage of T cell differentiation. J Immunol 1995;154:2125-2133.
24. Ihle JN, Keller J, Oroszzlan S, Henderson LE, Copeland TD, Fitch F, Prystowsky MB, Goldwasser E, Schrader JW, Paraszynski E, Dy M, and Lebel B: Biologic properties of homogenous interleukin 3. J Immunol 1983;131:282-287.
25. Razin E, Ihle JN, Seldin D, Mencia-Huerta J-M, Katz HR, LeBlanc PA, Hein A, Caulfield JP, Austen KF, and Stevens RL: Interleukin 3: A differentiation and growth factor for the mouse mast cell that contains chondroitin sulfate E proteoglycan. J Biol Chem 1984;132:1479-1486.
26. Ignatius MJ, Large TH, Houde M, Tawil JW, Barton A, Esch F, Carbonetto S, and Reichardt LF: Molecular cloning of the rat integrin alpha-1 subunit: A receptor for laminin and collagen. J Cell Biol 1990;111:709-720.
27. Briesewitz R, Epstein MR, and Marcantonio EE: Expression of native and truncated forms of the human integrin al subunit. J Biol Chem 1993;268:2989-2996.
28. Takada Y, and Hemler ME: The primary structure of the VLA-2 collagen receptor alpha2 subunit (platelet GP Ia): Homology to other integrins and the presence of a possible collagen-binding domain. J Cell Biol 1989;109:397-407.
29. Edelman J, Chan BMC, Uniyal S, Onodera H, Wang DZ, St. John NF, Damjanovich L, Latzer DB, Finberg RW, and Bergelson JM: The mouse VLA-2 homologue supports collagen and laminin adhesion but not virus binding. Cell Adh Commun 1994;2:131-143.
30. Hynes RO, Marcantonio EE, Stepp MA, Urry LA, and Yee GH: Integrin heterodimer and receptor complexity in avian and mammalian cells. J Cell Biol 1989;109:409-420.
31. Holers VM, Ruff TG, Parks DL, McDonald JA, Ballard LL, and Brown EJ: Molecular cloning of a murine fibronectin receptor and its expression during inflammation. Expression of VLA-5 is increased in activated peritoneal macrophages in a manner discordant from major histocompatibility complex class II. J Exp Med 1989;169:1589-1605.
32. Harlow E, and Lane D: Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, 1988.
33. a+-dependent amino acid transport system from Ehrlich ascites cell plasma membrane. Proc Natl Acad Sci USA 1988;85:7877-7881.
34. Gefter ML, Margulies DH, and Scharff MD: A simple method for polyethylene glycol-promoted hybridization of mouse myeloma cells. Somatic Cell Genet 1977;3:231-236.
35. Helmer ME, Huang C, Takada Y, Schwarz L, Strominger J, and Clabby ML: Characterization of the cell surface heterodimer VLA-4 and related peptides. J Biol Chem 1987;262:11478-11485.
36. Chan BMC, Wong JGP, Rao A, and Helmer ME: T cell receptordependent, antigen-specific stimulation of a murine T cell clone induces a transient, VLA protein-mediated binding to extracellular matrix. J Immunol 1991;147:398-404.
37. Chan BMC, Kassner PD, Schiro JA, Byers HR, Kupper TS, and Helmer ME: Distinct cellular functions mediated by different VLA integrin alpha subunit cytoplasmic domains. Cell 1992;68: 1051-1060.
38. Winston SE, and Fuller SA: In: Current Protocols in Immunology. Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, and Strober E (Eds.). Greene Publishing Associates & Wiley-Interscience, New York, 1991, pp. 8.10.1-17.
39. Chan BMC, and Hemler ME: Multiple functional forms of the integrin VLA-2 derived from a single alpha 2 cDNA clone: Interconversion of forms induced by an anti-beta 1 antibody. J Cell Biol 1993;120:537-543.
40. Ducharme LA, and Weis JH: Modulation of integrin expression during mast cell differentiation. Eur J Immunol 1992;22: 2603-2607.
41. Gurish MP, Bell AF, Smith TJ, Ducharme LA, Wang R-K, and Weis JH: Expression of murine β7, α4, and β1 integrin genes by rodent mast cells. J Immunol 1992;149:1964-1972.
42. McCormick JI, and Johnstone RM: Identification of the integrin α3b1 as a component of a partially purified amino acid transporter from Ehrlich cell plasma membranes. Biochem J 1995;311:743-751.